✦ LIBER ✦

Preoperative Chemotherapy plus Lapatinib or Trastuzumab or Both in HER2-Positive Operable Breast Cancer (CHERLOB Trial)

✍ Scribed by Valentina Guarneri; Antonio Frassoldati; Federico Piacentini; Gordana Jovic; Simona Giovannelli; Cristina Oliva; PierFranco Conte

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

5149 Randomized phase II trial of preope

✍ Guarneri, V.; Frassoldati, A.; Bottini, A.; Cagossi, K.; Cavanna, L.; Ravaioli, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Trastuzumab or lapatinib with standard c

✍ Alba, E; Albanell, J; de la Haba, J; Barnadas, A; Calvo, L; Sánchez-Rovira, P; R 📂 Article 📅 2014 🏛 Nature Publishing Group 🌐 English ⚖ 231 KB

Potential biomarkers of long-term benefi

✍ Montemurro, Filippo; Prat, Aleix; Rossi, Valentina; Valabrega, Giorgio; Sperinde 📂 Article 📅 2013 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 323 KB

A Meta-Analysis of Randomized Controlled

✍ Cun Liao; Fang Yin; Ping Huang; Yunfei Cao; Feng Gao 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 43 KB

Brain metastases in HER2-positive metast

✍ Kaplan, Muhammet Ali; Ertugrul, Hamza; Firat, Ugur; Kucukoner, Mehmet; İnal, Ali 📂 Article 📅 2014 🏛 Springer Japan 🌐 English ⚖ 204 KB

A multicenter trial evaluating retaspimy

✍ Modi, Shanu; Saura, Cristina; Henderson, Charles; Lin, Nancy U.; Mahtani, Reshma 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 287 KB